Rang	Name	Position
1	Dr. Bobak R. Azamian M.D.	Co-Founder, President, CEO & Chairman
2	Mr. Jeffrey S. Farrow CPA	CFO & Chief Strategy Officer
3	Dr. Seshadri Neervannan Ph.D.	Chief Operating Officer
4	Dr. Bryan Wahl J.D., M.D.	General Counsel & Corporate Secretary
5	Mr. David Nakasone	Head of Investor Relations
6	Ms. Adrienne Kemp	Vice President of Corporate Communications
7	Mr. Matthew Rossen M.B.A.	Vice President of Marketing
8	Mr. Scott Youmans	Vice President of Sales
9	Ms. Dianne C. Whitfield M.S.W.	Chief Human Resources Officer
10	Dr. Elizabeth Yeu-Lin M.D.	Chief Medical Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Deep Track Capital, LP	8,62%	0,32 Mrd. USD
2	BlackRock Inc	8,35%	0,31 Mrd. USD
3	RTW INVESTMENTS, LLC	7,86%	0,29 Mrd. USD
4	Paradigm Biocapital Advisors LP	6,52%	0,24 Mrd. USD
5	HHG PLC	5,27%	0,20 Mrd. USD
6	Morgan Stanley - Brokerage Accounts	4,57%	0,17 Mrd. USD
7	Vanguard Capital Management, LLC	4,14%	0,15 Mrd. USD
8	Jennison Associates LLC	3,91%	0,15 Mrd. USD
9	Millennium Management LLC	3,35%	0,12 Mrd. USD
10	Bank of America Corp	2,81%	0,10 Mrd. USD
11	TANG CAPITAL MANAGEMENT LLC	2,79%	0,10 Mrd. USD
12	Geode Capital Management, LLC	2,63%	0,10 Mrd. USD
13	State Street Corp	2,30%	0,09 Mrd. USD
14	Assenagon Asset Management SA	2,23%	0,08 Mrd. USD
15	Driehaus Capital Management LLC	2,18%	0,08 Mrd. USD
16	Lord, Abbett & Co LLC	1,98%	0,07 Mrd. USD
17	Amvescap Plc.	1,74%	0,07 Mrd. USD
18	FMR Inc	1,72%	0,06 Mrd. USD
19	Frazier Life Sciences Management, L.P.	1,71%	0,06 Mrd. USD
20	D. E. Shaw & Co LP	1,67%	0,06 Mrd. USD